DGAP-News: SHOP APOTHEKE EUROPE NV / Keyword (s): Sales development / Preliminary results


11.01.2022 / 07:00
The issuer is solely responsible for the content of this advertisement.


  • Group sales in Q4 were up 21.0% compared to Q3.
  • Year-on-year sales growth for the full year 2021 was up 9.5% to 1.06 billion euros.
  • Everything But Rx Strong Again: Annual Sales Up 22.4% Over Last Year; in Q4 24.8%.
  • The number of active customers increased 1.6 million year-over-year (0.5 million in the fourth quarter) to 7.9 million.
  • Step towards a customer-centric e-pharmacy platform with market launch last December.

Sevenum, January 11, 2022. According to preliminary and unaudited calculations, sales of SHOP APOTHEKE EUROPE increased by 9.5% to reach 1.06 billion euros. In the fourth quarter, sales amounted to 287.8 million euros, an increase of 8.7% compared to the strong fourth quarter of the previous year. The group gained 1.6 million active customers during the year, including 0.5 million in the fourth quarter. The total number of active customers reached 7.9 million at the end of 2021.

Stefan Feltens, CEO of SHOP APOTHEKE EUROPE: “We are looking back on a very strong fourth quarter. We have successfully returned to our old path of growth. In 2021, we made significant progress in implementing SHOP APOTHEKE EUROPE’s strategy to become a center -Pharmacy platform: this includes the expansion of our digital health services, the deployment of our delivery service the same day SHOP APOTHEKE NOW! in the metropolitan areas of Germany and the opening of our new next-generation logistics center. Most recently, in December, we took a big step forward in expanding our product line by adding 20,000 healthcare-related products through the launch of our own marketplace in Germany. Last but not least, we have been ready for e-Rx in Germany since last summer. We have successfully processed customers’ first e-Rx prescriptions since then. “

During the year 2021, the most important segment in terms of sales, DACH, which includes the business activities of SHOP APOTHEKE EUROPE in Germany, Austria and Switzerland, increased by 3.9% compared to 2020. Sales increased to 847 million euros from 815.4 million euros the previous year. year; Rx sales were down 34.7% to 143.3 million euros, everything but Rx on the contrary increased 18.1% to 703.7 million. In the fourth quarter, DACH sales amounted to 228.7 million euros (previous year: 223.7 million). In the International segment (France, Belgium, Italy and the Netherlands), SHOP APOTHEKE EUROPE increased its sales by 39.6% to 213.1 million euros in 2021 (152.7 million euros the previous year ) and 44.1% to 59.1 million euros in the fourth quarter.

CFO Jasper Eenhorst comments: “We achieved our full year goal of increasing total sales by approximately 10% thanks to an impressive 21% growth spurt from the third to the fourth quarter. Our marketing proposals and activities have been successful in increasing our total active customer base from 0.5 million to 7.9 million. Our new logistics center handled orders without a hitch. We are ready for 2022. “

All published figures are preliminary and unaudited. SHOP APOTHEKE EUROPE will publish on March 2, 2022 the full annual report for the financial year 2021.


SHOP APOTHEKE EUROPE is one of the leading and fastest growing online pharmacies in Europe, currently operating in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Based in the Dutch logistics hub of Sevenum near Venlo with establishments in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven, SHOP APOTHEKE EUROPE offers its customers a wide range of more than 100,000 original products at attractive prices: OTC, beauty and personal care products as well as prescription drugs, supplemented by high quality food and natural health products, low carbohydrate products and sports nutrition. Currently, 7.9 million active customers trust SHOP APOTHEKE EUROPE.

Since safe and reliable pharmaceutical advice is a top priority at SHOP APOTHEKE EUROPE, the e-pharmacy provides comprehensive pharmaceutical advice services.

In anticipation of the introduction of electronic prescriptions in Germany, the company will further enhance the customer experience with a focus on digital disease-specific drug management services following the acquisition of SMARTPATIENT in January 2021. It s This is a key part of SHOP APOTHEKE EUROPE’s strategy to transform from a simple online retailer to a truly customer-centric e-pharmacy platform.

SHOP APOTHEKE EUROPE NV has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 2016 and is part of the SDAX stock market index.


Commerce and popular media:
Sven Schirmer
Phone: +49 221 99 53 44 31
Email: [email protected]

Financial media:
Bettina Fries
Phone: +49 211 75 80 779
Email: [email protected]

Investor Relations:
Carmen herkenrath
Phone. : +31 77 850 6109
Email: [email protected]

Thomas Schnorrenberg
Mobile: +49 151 465 31317
Email: [email protected]

01.11.2022 Distribution of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this advertisement.

DGAP’s distribution services include regulatory announcements, financial / corporate news, and press releases.
Archives on

Comments are closed.